Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice.
Brown, B., Gabra, M. I., & Pellman, H., (2017). Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice. Papillomavirus Research, 3, 42-45.
Human papillomavirus (HPV) vaccine initiation in minority Americans.
De, P., & Budhwani, H., (2017). Human papillomavirus (HPV) vaccine initiation in minority Americans. Public Health, 144, 86-91.
Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.
Chesson, H. W., Meites, E., Ekwueme, D. U., Saraiya, M., & Markowitz, L. E., (2018). Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States. Vaccine, 36, 4362-4368.
“HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papilloma virus vaccination.
Hendry, M., Lewis, R., Clements, A., Damery, S., & Wilkinson, C., (2013). “HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papilloma virus vaccination. Vaccine, 31, 5152-5167.
Vaccine programme stakeholder perspectives on a hypothetical single-dose human papilloma virus (HPV) vaccine schedule in low and middle-income countries.
Gallagher, K. E., Kelly, H., Cocks, N., Dixon, S., Mounier-Jack, S., Howard, N., & Watson-Jones, D., (2018). Vaccine programme stakeholder perspectives on a hypothetical single-dose human papilloma virus (HPV) vaccine schedule in low and middle-income countries. Papillomavirus Research, 6, 33-40.
Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
Gallagher, K. E., Howard, N., Kabakama, S., Mounier-Jack, S., Burchett, H. E. D., LaMontagne, D. S., & Watson-Jones, D., (2017). Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016. Papillomavirus Research, 4, 72-78.
Understanding human papilloma virus vaccine uptake.
Fisher, W. A., (2012). Understanding human papilloma virus vaccine uptake. Vaccine, 30S, F149-F156.
Early outcomes of a multilevel human papilloma virus vaccination pilot intervention in federally qualified health centers.
Fisher-Borne, M., Preiss, A. J., Black, M., Roberts, K., & Saslow, D., (2018). Early outcomes of a multilevel human papilloma virus vaccination pilot intervention in federally qualified health centers. Academic Pediatrics, 18(2S), S79-S84.
Human papillomavirus vaccination: Narrative review of studies on how providers’ vaccine communication affects attitudes and uptake.
Dempsey, A. F., & O’Leary, S. T., (2018). Human papillomavirus vaccination: Narrative review of studies on how providers’ vaccine communication affects attitudes and uptake. Academic Pediatrics, 18 (S2), S23-S27.
Human papillomavirus vaccine acceptability among parents of adolescent girls in a rural area, Mysore, India.
Degarege, A., Krupp, K., Fennie, K., Srinivas, V., Li, T., Stephens, D. P., Marlow, L. A. V., Arun, A., & Madhivanan, P., (2018). Human papillomavirus vaccine acceptability among parents of adolescent girls in a rural area, Mysore, India. Journal of Pediatric and Adolescent Gynecology, 31, 583-591.